Cocrystal Pharma Inc is a biotechnology company pioneering antiviral therapeutics, aiming to revolutionize the treatment of viral infections such as hepatitis, influenza, and noroviruses.

Cocrystal Pharma Inc’s financial struggles and fluctuating stock price raise concerns about its ability to justify its valuation, despite its innovative approach to antiviral therapeutics.